SPONSOR
Hunan Cancer Hospital
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: Carcinoma, Non-Small-Cell LungNasopharyngeal CarcinomaHerpesvirus 4, HumanGastric CancerHead and Neck Cancer Squamous Cell Carcinoma
Hunan Cancer Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Carcinoma, Non-Small-Cell Lung, Nasopharyngeal Carcinoma, Herpesvirus 4, Human, Gastric Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hunan Cancer Hospital
How many clinical trials has Hunan Cancer Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Hunan Cancer Hospital, of which 4 are actively recruiting participants. These trials cover conditions including Carcinoma, Non-Small-Cell Lung, Nasopharyngeal Carcinoma, Herpesvirus 4, Human. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hunan Cancer Hospital research focus on?
Hunan Cancer Hospital clinical trials span Carcinoma, Non-Small-Cell Lung, Nasopharyngeal Carcinoma, Herpesvirus 4, Human, Gastric Cancer, Head and Neck Cancer Squamous Cell Carcinoma. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hunan Cancer Hospital clinical trial?
To participate in a Hunan Cancer Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hunan Cancer Hospital trials with current recruitment status updated daily.
Clinical Trials by Hunan Cancer Hospital
NCT05940532 Phase 2
Recruiting
A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
Carcinoma, Non-Small-Cell Lung
NCT06321939
Recruiting
Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
NCT06543108
Recruiting
Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
Gastric Cancer
NCT06752798 Phase 2
Recruiting
Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC
Head and Neck Cancer Squamous Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology